nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF1—nerve—peripheral nervous system neoplasm	0.00694	0.247	CbGeAlD
Pentosan Polysulfate—FGF1—ganglion—peripheral nervous system neoplasm	0.00685	0.244	CbGeAlD
Pentosan Polysulfate—FGF2—trigeminal ganglion—peripheral nervous system neoplasm	0.00453	0.161	CbGeAlD
Pentosan Polysulfate—FGF1—trigeminal ganglion—peripheral nervous system neoplasm	0.00337	0.12	CbGeAlD
Pentosan Polysulfate—FGF1—brainstem—peripheral nervous system neoplasm	0.00298	0.106	CbGeAlD
Pentosan Polysulfate—FGF2—cerebellum—peripheral nervous system neoplasm	0.00198	0.0702	CbGeAlD
Pentosan Polysulfate—FGF1—cerebellum—peripheral nervous system neoplasm	0.00147	0.0522	CbGeAlD
Pentosan Polysulfate—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000766	0.00151	CcSEcCtD
Pentosan Polysulfate—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000762	0.0015	CcSEcCtD
Pentosan Polysulfate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000757	0.00149	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000749	0.00147	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000747	0.00147	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000746	0.00147	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000741	0.00146	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000741	0.00146	CcSEcCtD
Pentosan Polysulfate—Alopecia—Etoposide—peripheral nervous system neoplasm	0.00074	0.00145	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000738	0.00145	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000737	0.00145	CcSEcCtD
Pentosan Polysulfate—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000735	0.00145	CcSEcCtD
Pentosan Polysulfate—Oedema—Vincristine—peripheral nervous system neoplasm	0.000734	0.00144	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000731	0.00144	CcSEcCtD
Pentosan Polysulfate—Infection—Vincristine—peripheral nervous system neoplasm	0.000729	0.00143	CcSEcCtD
Pentosan Polysulfate—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000726	0.00143	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000719	0.00141	CcSEcCtD
Pentosan Polysulfate—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000717	0.00141	CcSEcCtD
Pentosan Polysulfate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000717	0.00141	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000715	0.0014	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000714	0.0014	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000712	0.0014	CcSEcCtD
Pentosan Polysulfate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000711	0.0014	CcSEcCtD
Pentosan Polysulfate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000711	0.0014	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00071	0.0014	CcSEcCtD
Pentosan Polysulfate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000702	0.00138	CcSEcCtD
Pentosan Polysulfate—Anorexia—Vincristine—peripheral nervous system neoplasm	0.0007	0.00138	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000694	0.00136	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000693	0.00136	CcSEcCtD
Pentosan Polysulfate—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000689	0.00135	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000688	0.00135	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000688	0.00135	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000684	0.00134	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000679	0.00134	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000679	0.00133	CcSEcCtD
Pentosan Polysulfate—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000677	0.00133	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000677	0.00133	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000676	0.00133	CcSEcCtD
Pentosan Polysulfate—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000673	0.00132	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000672	0.00132	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000671	0.00132	CcSEcCtD
Pentosan Polysulfate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00067	0.00132	CcSEcCtD
Pentosan Polysulfate—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000669	0.00132	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000669	0.00131	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000668	0.00131	CcSEcCtD
Pentosan Polysulfate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000665	0.00131	CcSEcCtD
Pentosan Polysulfate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000665	0.00131	CcSEcCtD
Pentosan Polysulfate—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000664	0.00131	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000662	0.0013	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000659	0.0013	CcSEcCtD
Pentosan Polysulfate—Malaise—Etoposide—peripheral nervous system neoplasm	0.000657	0.00129	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000652	0.00128	CcSEcCtD
Pentosan Polysulfate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000651	0.00128	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00065	0.00128	CcSEcCtD
Pentosan Polysulfate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000649	0.00128	CcSEcCtD
Pentosan Polysulfate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000645	0.00127	CcSEcCtD
Pentosan Polysulfate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000644	0.00127	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000643	0.00126	CcSEcCtD
Pentosan Polysulfate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000639	0.00126	CcSEcCtD
Pentosan Polysulfate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000639	0.00126	CcSEcCtD
Pentosan Polysulfate—Rash—Topotecan—peripheral nervous system neoplasm	0.000639	0.00126	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000638	0.00125	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000638	0.00125	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000636	0.00125	CcSEcCtD
Pentosan Polysulfate—Headache—Topotecan—peripheral nervous system neoplasm	0.000635	0.00125	CcSEcCtD
Pentosan Polysulfate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000634	0.00125	CcSEcCtD
Pentosan Polysulfate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000634	0.00125	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000633	0.00124	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000633	0.00124	CcSEcCtD
Pentosan Polysulfate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000631	0.00124	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000631	0.00124	CcSEcCtD
Pentosan Polysulfate—Headache—Tretinoin—peripheral nervous system neoplasm	0.00063	0.00124	CcSEcCtD
Pentosan Polysulfate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00063	0.00124	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000628	0.00123	CcSEcCtD
Pentosan Polysulfate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000628	0.00123	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000628	0.00123	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000626	0.00123	CcSEcCtD
Pentosan Polysulfate—Rash—Melphalan—peripheral nervous system neoplasm	0.000626	0.00123	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000625	0.00123	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000623	0.00122	CcSEcCtD
Pentosan Polysulfate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000619	0.00122	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000618	0.00121	CcSEcCtD
Pentosan Polysulfate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000613	0.0012	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000605	0.00119	CcSEcCtD
Pentosan Polysulfate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000605	0.00119	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000602	0.00118	CcSEcCtD
Pentosan Polysulfate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000602	0.00118	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.0006	0.00118	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.0006	0.00118	CcSEcCtD
Pentosan Polysulfate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000597	0.00117	CcSEcCtD
Pentosan Polysulfate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000597	0.00117	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.00117	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000591	0.00116	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—peripheral nervous system neoplasm	0.000591	0.00116	CcSEcCtD
Pentosan Polysulfate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000589	0.00116	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000584	0.00115	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000583	0.00115	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000582	0.00114	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00058	0.00114	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000579	0.00114	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000575	0.00113	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000571	0.00112	CcSEcCtD
Pentosan Polysulfate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000567	0.00111	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000564	0.00111	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000562	0.00111	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.0011	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.00109	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000542	0.00106	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000541	0.00106	CcSEcCtD
Pentosan Polysulfate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000539	0.00106	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000535	0.00105	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000535	0.00105	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000534	0.00105	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000533	0.00105	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00053	0.00104	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00053	0.00104	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.00104	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000522	0.00103	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000521	0.00102	CcSEcCtD
Pentosan Polysulfate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000518	0.00102	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000517	0.00102	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000509	0.001	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000509	0.001	CcSEcCtD
Pentosan Polysulfate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000509	0.001	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000999	CcSEcCtD
Pentosan Polysulfate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000504	0.00099	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000502	0.000987	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000985	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000985	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000498	0.00098	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000495	0.000973	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.00097	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000493	0.000969	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.000965	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00049	0.000964	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00049	0.000963	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000488	0.000959	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000486	0.000956	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000485	0.000954	CcSEcCtD
Pentosan Polysulfate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000484	0.000952	CcSEcCtD
Pentosan Polysulfate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00048	0.000944	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00048	0.000943	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000478	0.00094	CcSEcCtD
Pentosan Polysulfate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000477	0.000938	CcSEcCtD
Pentosan Polysulfate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000472	0.000929	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000927	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000927	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00047	0.000925	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00047	0.000924	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000924	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000467	0.000917	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000915	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000911	CcSEcCtD
Pentosan Polysulfate—Rash—Vincristine—peripheral nervous system neoplasm	0.000463	0.00091	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000462	0.000909	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000906	CcSEcCtD
Pentosan Polysulfate—Headache—Vincristine—peripheral nervous system neoplasm	0.00046	0.000904	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000897	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000892	CcSEcCtD
Pentosan Polysulfate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.00089	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000444	0.000873	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000438	0.000861	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000437	0.00086	CcSEcCtD
Pentosan Polysulfate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000436	0.000857	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000856	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000847	CcSEcCtD
Pentosan Polysulfate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000421	0.000827	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000815	CcSEcCtD
Pentosan Polysulfate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000413	0.000811	CcSEcCtD
Pentosan Polysulfate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000409	0.000805	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000409	0.000804	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000407	0.0008	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000796	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000791	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000398	0.000859	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000398	0.000859	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI3K/AKT activation—AKT1—peripheral nervous system neoplasm	0.000396	0.000854	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000394	0.000851	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000393	0.000773	CcSEcCtD
Pentosan Polysulfate—FGF1—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	0.000392	0.000847	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD34—peripheral nervous system neoplasm	0.000391	0.000845	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000391	0.000844	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	0.000391	0.000844	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—NRAS—peripheral nervous system neoplasm	0.000391	0.000844	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000391	0.000844	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000389	0.00084	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	0.000387	0.000836	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000386	0.000758	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signal transduction—NRAS—peripheral nervous system neoplasm	0.000385	0.00083	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000384	0.000829	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000384	0.000829	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000754	CcSEcCtD
Pentosan Polysulfate—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	0.000383	0.000828	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SLC2A1—peripheral nervous system neoplasm	0.000383	0.000826	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—NRAS—peripheral nervous system neoplasm	0.000383	0.000826	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	0.000382	0.000825	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000382	0.000825	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.000381	0.000822	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000745	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—NRAS—peripheral nervous system neoplasm	0.000379	0.000818	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000378	0.000743	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000742	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000377	0.000814	CbGpPWpGaD
Pentosan Polysulfate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000738	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—peripheral nervous system neoplasm	0.000375	0.000737	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000375	0.000736	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—NRAS—peripheral nervous system neoplasm	0.000373	0.000806	CbGpPWpGaD
Pentosan Polysulfate—Headache—Etoposide—peripheral nervous system neoplasm	0.000373	0.000732	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000732	CcSEcCtD
Pentosan Polysulfate—FGF2—PI-3K cascade—AKT1—peripheral nervous system neoplasm	0.00037	0.000798	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000724	CcSEcCtD
Pentosan Polysulfate—FGF4—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000368	0.000795	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by Insulin receptor—HRAS—peripheral nervous system neoplasm	0.000366	0.00079	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000719	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.000362	0.000781	CbGpPWpGaD
Pentosan Polysulfate—FGF2—PI3K/AKT activation—AKT1—peripheral nervous system neoplasm	0.000361	0.000779	CbGpPWpGaD
Pentosan Polysulfate—FGF2—GAB1 signalosome—AKT1—peripheral nervous system neoplasm	0.000358	0.000773	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD34—peripheral nervous system neoplasm	0.000357	0.000771	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—NRAS—peripheral nervous system neoplasm	0.000356	0.00077	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—NRAS—peripheral nervous system neoplasm	0.000356	0.00077	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—NRAS—peripheral nervous system neoplasm	0.000356	0.00077	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—NRAS—peripheral nervous system neoplasm	0.000353	0.000763	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000353	0.000694	CcSEcCtD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000352	0.000761	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000689	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.00035	0.000756	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.00035	0.000756	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—peripheral nervous system neoplasm	0.00035	0.000755	CbGpPWpGaD
Pentosan Polysulfate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000687	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by PDGF—NRAS—peripheral nervous system neoplasm	0.000349	0.000753	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000348	0.000752	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000348	0.000751	CbGpPWpGaD
Pentosan Polysulfate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000684	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000684	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000683	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000346	0.000748	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000344	0.000742	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000675	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000343	0.000741	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000343	0.00074	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.00067	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000665	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000334	0.000721	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000655	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—NCAM1—peripheral nervous system neoplasm	0.000333	0.000719	CbGpPWpGaD
Pentosan Polysulfate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000651	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—NRAS—peripheral nervous system neoplasm	0.00033	0.000712	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	0.000328	0.000709	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000642	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000323	0.000697	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000633	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000632	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000632	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000319	0.000689	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000625	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000625	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—HGF—peripheral nervous system neoplasm	0.000318	0.000686	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000318	0.000686	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000318	0.000686	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PPP3R1—peripheral nervous system neoplasm	0.000317	0.000685	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000316	0.000682	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000315	0.000679	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	0.000313	0.000675	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000312	0.000675	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—CASP3—peripheral nervous system neoplasm	0.000309	0.000667	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	0.000308	0.000666	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000606	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	0.000307	0.000663	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000307	0.000663	CbGpPWpGaD
Pentosan Polysulfate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000602	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000305	0.00066	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000305	0.000658	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—HRAS—peripheral nervous system neoplasm	0.000304	0.000656	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000597	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—NCAM1—peripheral nervous system neoplasm	0.000304	0.000655	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.000303	0.000654	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.000302	0.000652	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000594	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000593	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—ENO2—peripheral nervous system neoplasm	0.000301	0.000651	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.0003	0.000647	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000588	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	0.000299	0.000646	CbGpPWpGaD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000586	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000584	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	0.000295	0.000636	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000578	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000577	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.00029	0.000626	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00029	0.00057	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.00029	0.000626	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000288	0.000622	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.000286	0.000617	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.000286	0.000617	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.000286	0.000617	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.000285	0.000616	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000285	0.00056	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000283	0.000612	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MET—peripheral nervous system neoplasm	0.000282	0.000609	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000281	0.000607	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	0.000281	0.000607	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000552	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000281	0.000607	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	0.00028	0.000604	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.00028	0.000604	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000548	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000279	0.000601	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—HRAS—peripheral nervous system neoplasm	0.000277	0.000598	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000544	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	0.000276	0.000596	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000541	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—ENO2—peripheral nervous system neoplasm	0.000275	0.000593	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00054	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	0.000273	0.00059	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000536	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000272	0.000588	CbGpPWpGaD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000534	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.000271	0.000585	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000271	0.000585	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.00027	0.000582	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000268	0.00058	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000527	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000266	0.000575	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000521	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000265	0.000571	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000265	0.000571	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	0.000264	0.000571	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000264	0.00057	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000518	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000518	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—IFNB1—peripheral nervous system neoplasm	0.000261	0.000564	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000261	0.000563	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—HRAS—peripheral nervous system neoplasm	0.000261	0.000563	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	0.000261	0.000563	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	0.000261	0.000563	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	0.00026	0.000562	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	0.000258	0.000558	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000257	0.000554	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000256	0.000553	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	0.000255	0.000551	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.0005	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000253	0.000547	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000253	0.000545	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.000253	0.000545	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.000253	0.000545	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.000253	0.000545	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000496	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.00025	0.00054	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	0.000248	0.000536	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000248	0.000536	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	0.000247	0.000534	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000247	0.000533	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000247	0.000532	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000246	0.000531	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000483	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000482	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—AKT1—peripheral nervous system neoplasm	0.000245	0.000528	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000479	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000244	0.000526	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000243	0.000525	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000243	0.000524	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000243	0.000524	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—HRAS—peripheral nervous system neoplasm	0.000241	0.000521	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	0.000241	0.000521	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000241	0.00052	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000239	0.000517	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNB1—peripheral nervous system neoplasm	0.000238	0.000514	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000238	0.000513	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000464	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000235	0.000507	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000234	0.000505	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PTPN11—peripheral nervous system neoplasm	0.000232	0.0005	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000231	0.000499	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.00023	0.000497	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—AKT1—peripheral nervous system neoplasm	0.00023	0.000497	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	0.00023	0.000497	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	0.00023	0.000497	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.00023	0.000496	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	0.000228	0.000493	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000448	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000447	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000226	0.000488	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	0.000225	0.000486	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000224	0.000483	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000222	0.00048	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SLC2A1—peripheral nervous system neoplasm	0.000222	0.000478	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	0.000221	0.000478	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000433	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000429	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000217	0.000468	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000216	0.000466	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTPN11—peripheral nervous system neoplasm	0.000214	0.000462	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—AKT1—peripheral nervous system neoplasm	0.000213	0.00046	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000417	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000415	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000413	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000413	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00041	CcSEcCtD
Pentosan Polysulfate—FGF2—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000206	0.000445	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000401	CcSEcCtD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000204	0.00044	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HGF—peripheral nervous system neoplasm	0.000202	0.000435	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.0002	0.000431	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000389	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000385	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000195	0.000421	CbGpPWpGaD
Pentosan Polysulfate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000382	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000382	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00038	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.000192	0.000414	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HGF—peripheral nervous system neoplasm	0.000184	0.000397	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.00036	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—ERBB2—peripheral nervous system neoplasm	0.000183	0.000396	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000183	0.000395	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000182	0.000393	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000178	0.000384	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000175	0.000378	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	0.000175	0.000377	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000172	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERBB2—peripheral nervous system neoplasm	0.000169	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	0.000168	0.000363	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000167	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000157	0.000339	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000157	0.000339	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000157	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000155	0.000334	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000152	0.000328	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00015	0.000324	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000149	0.000322	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	0.000148	0.00032	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTPN11—peripheral nervous system neoplasm	0.000147	0.000318	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.000146	0.000315	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000143	0.000308	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRAS—peripheral nervous system neoplasm	0.000139	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000138	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000137	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000136	0.000294	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTPN11—peripheral nervous system neoplasm	0.000136	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTPN11—peripheral nervous system neoplasm	0.000134	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	0.000133	0.000287	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRAS—peripheral nervous system neoplasm	0.000129	0.000278	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000125	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTPN11—peripheral nervous system neoplasm	0.000124	0.000267	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—peripheral nervous system neoplasm	0.00012	0.000259	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000118	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—peripheral nervous system neoplasm	0.000116	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000115	0.000248	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000111	0.00024	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000107	0.000232	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—peripheral nervous system neoplasm	0.000107	0.000232	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	0.000107	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—peripheral nervous system neoplasm	0.000106	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—peripheral nervous system neoplasm	0.000102	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000101	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000101	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—peripheral nervous system neoplasm	9.81e-05	0.000212	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—peripheral nervous system neoplasm	9.79e-05	0.000211	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	9.73e-05	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.51e-05	0.000205	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	9.42e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—peripheral nervous system neoplasm	9.41e-05	0.000203	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.01e-05	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—peripheral nervous system neoplasm	9e-05	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.95e-05	0.000193	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—peripheral nervous system neoplasm	8.85e-05	0.000191	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.67e-05	0.000187	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	8.59e-05	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.39e-05	0.000181	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—peripheral nervous system neoplasm	8.31e-05	0.000179	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—peripheral nervous system neoplasm	8.17e-05	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—peripheral nervous system neoplasm	8.07e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—peripheral nervous system neoplasm	7.61e-05	0.000164	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.52e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—peripheral nervous system neoplasm	7.45e-05	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—peripheral nervous system neoplasm	6.94e-05	0.00015	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.89e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.86e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.82e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.59e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—peripheral nervous system neoplasm	6.47e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.22e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—peripheral nervous system neoplasm	5.97e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—peripheral nervous system neoplasm	5.9e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.82e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.72e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—peripheral nervous system neoplasm	5.71e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—peripheral nervous system neoplasm	5.45e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.33e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—peripheral nervous system neoplasm	5.28e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.22e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—peripheral nervous system neoplasm	5.21e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.86e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—peripheral nervous system neoplasm	4.81e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.38e-05	9.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.18e-05	9.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.99e-05	8.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.82e-05	8.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.69e-05	7.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.37e-05	7.27e-05	CbGpPWpGaD
